Fine-scale Staging of T Cell Lineage Commitment in Adult Mouse Thymus
Overview
Authors
Affiliations
T cell development is marked by the loss of alternative lineage choices accompanying specification and commitment to the T cell lineage. Commitment occurs between the CD4 and CD8 double-negative (DN) 2 and DN3 stages in mouse early T cells. To determine the gene regulatory changes that accompany commitment, we sought to distinguish and characterize the earliest committed wild-type DN adult thymocytes. A transitional cell population, defined by the first downregulation of surface c-Kit expression, was found to have lost the ability to differentiate into dendritic cells and NK cells when cultured without Notch-Delta signals. In the presence of Notch signaling, this subset generates T lineage descendants in an ordered precursor-product relationship between DN2, with the highest levels of surface c-Kit, and c-Kit-low DN3 cells. These earliest committed cells show only a few differences in regulatory gene expression, compared with uncommitted DN2 cells. They have not yet established the full expression of Notch-related and T cell differentiation genes characteristic of DN3 cells before beta selection. Instead, the downregulation of select stem cell and non-T lineage genes appears to be key to the extinction of alternative lineage choices.
T Cell Development: From T-Lineage Specification to Intrathymic Maturation.
Golzari-Sorkheh M, Yoganathan K, Chen E, Singh J, Zuniga-Pflucker J Adv Exp Med Biol. 2025; 1471:81-137.
PMID: 40067585 DOI: 10.1007/978-3-031-77921-3_4.
The thymus road to a T cell: migration, selection, and atrophy.
Ruiz Perez M, Vandenabeele P, Tougaard P Front Immunol. 2024; 15:1443910.
PMID: 39257583 PMC: 11384998. DOI: 10.3389/fimmu.2024.1443910.
Transcriptional network dynamics in early T cell development.
Shin B, Chang S, MacNabb B, Rothenberg E J Exp Med. 2024; 221(10).
PMID: 39167073 PMC: 11338287. DOI: 10.1084/jem.20230893.
T-cell commitment inheritance-an agent-based multi-scale model.
Andersson E, Rothenberg E, Peterson C, Olariu V NPJ Syst Biol Appl. 2024; 10(1):40.
PMID: 38632273 PMC: 11024127. DOI: 10.1038/s41540-024-00368-y.
Viable mutations of mouse midnolin suppress B cell malignancies.
Zhong X, Peddada N, Moresco J, Wang J, Jiang Y, Rios J J Exp Med. 2024; 221(6).
PMID: 38625151 PMC: 11022886. DOI: 10.1084/jem.20232132.